Literature DB >> 30528390

Biochemical and morphological classification of disease-associated alpha-synuclein mutants aggregates.

Goki Tanaka1, Tomoyuki Yamanaka2, Yoshiaki Furukawa3, Naoko Kajimura4, Kaoru Mitsuoka4, Nobuyuki Nukina5.   

Abstract

Alpha-synuclein (a-syn) aggregation in brain is implicated in several synucleinopathies, including Parkinson's disease (PD), dementia with Lewy bodies (DLB), and multiple system atrophy (MSA). Until date, at least six disease-associated mutations in a-syn (namely A30P, E46K, H50Q, G51D, A53T, and A53E) are known to cause dominantly inherited familial forms of synucleinopathies. Previous studies using recombinant proteins have reported that a subset of disease-associated mutants show higher aggregation propensities and form spectroscopically distinguishable aggregates compared to wild-type (WT). However, morphological and biochemical comparison of the aggregates for all disease-associated a-syn mutants have not yet been performed. In this study, we performed electron microscopic examination, guanidinium hydrochloride (GdnHCl) denaturation, and protease digestion to classify the aggregates from their respective point mutations. Using electron microscopy we observed variations of amyloid fibrillar morphologies among the aggregates of a-syn mutants, mainly categorized into two groups: twisted fibrils observed for both WT and E46K while straight fibrils for the other mutants. GdnHCl denaturation experiments revealed the a-syn mutants except for E46K were more resistant than WT against the denaturation. Mass spectrometry analysis of protease-treated aggregates showed a variety of protease-resistant cores, which may correspond to their morphological properties. The difference of their properties could be implicated in the clinicopathological difference of synucleinopathies with those mutations.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alpha-synuclein; Disease-associated mutation; Protein aggregation; Synucleinopathy

Mesh:

Substances:

Year:  2018        PMID: 30528390     DOI: 10.1016/j.bbrc.2018.11.200

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  5 in total

Review 1.  What is strain in neurodegenerative diseases?

Authors:  Ye Tian; Lanxia Meng; Zhentao Zhang
Journal:  Cell Mol Life Sci       Date:  2019-09-17       Impact factor: 9.261

Review 2.  The emerging role of α-synuclein truncation in aggregation and disease.

Authors:  Zachary A Sorrentino; Benoit I Giasson
Journal:  J Biol Chem       Date:  2020-05-18       Impact factor: 5.157

3.  Autofluorescence-based analyses of intranuclear inclusions of Fragile X-associated tremor/ataxia syndrome.

Authors:  Lisa Ma; Paul J Hagerman
Journal:  Biotechniques       Date:  2020-06-03       Impact factor: 1.993

4.  Composition of the Intranuclear Inclusions of Fragile X-associated Tremor/Ataxia Syndrome.

Authors:  Lisa Ma; Anthony W Herren; Glenda Espinal; Jamie Randol; Bridget McLaughlin; Veronica Martinez-Cerdeño; Isaac N Pessah; Randi J Hagerman; Paul J Hagerman
Journal:  Acta Neuropathol Commun       Date:  2019-09-03       Impact factor: 7.801

5.  RT-QuIC-based detection of alpha-synuclein seeding activity in brains of dementia with Lewy Body patients and of a transgenic mouse model of synucleinopathy.

Authors:  Jung-Youn Han; Hyung-Sup Jang; Alison J E Green; Young Pyo Choi
Journal:  Prion       Date:  2020-12       Impact factor: 3.931

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.